<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
     xmlns:admin="http://webns.net/mvcb/"
     xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
     xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>kashannews&#45; Top Independent Global News Outlets You Should Follow Today &#45; : VIDEOS</title>
<link>https://news.adab.space/rss/category/videos</link>
<description>kashannews&#45; Top Independent Global News Outlets You Should Follow Today &#45; : VIDEOS</description>
<dc:language>en</dc:language>
<dc:rights>Copyright 2024 Kashan News,&#45; All Rights Reserved.</dc:rights>

<item>
<title>108 New Covid&#45;19 Cases In Gujarat, One Death; Active Caseload Rises To 461</title>
<link>https://news.adab.space/108-new-covid-19-cases-in-gujarat-one-death-active-caseload-rises-to-461</link>
<guid>https://news.adab.space/108-new-covid-19-cases-in-gujarat-one-death-active-caseload-rises-to-461</guid>
<description><![CDATA[ Ahmedabad: Gujarat has recorded 108 new coronavirus positive cases and one death, the state health department said on Tuesday.
These cases were registered in the last 24 hours, taking the total count of active infections to 461, it said in a release.
One patient succumbed to the infection in this fresh wave, it said.
Of the total 461 active patients, 20 are hospitalised, while 441 others are receiving treatment in home isolation, it said, adding that 43 patients have also been discharged following recovery.
All the cases which are emerging in Gujarat are of the Omicron LF.7.9 and XFG Recombinant sub-variant, which causes mild fever and cough, the release said.
There is no need to panic as COVID-19 cases usually see a &quot;rising trend&quot; every 6 or 8 months, it added.
No information about the patient, who succumbed to the infection in this new wave, was given.
(This report has been published as part of the auto-generated syndicate wire feed. Apart from the headline, no editing has been done in the copy by ABP Live.) ]]></description>
<enclosure url="https://feeds.abplive.com/onecms/images/uploaded-images/2025/06/01/37043d2d821c5c4bd37cc43390f7e1c417487807729881200_original.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 30 Jun 2026 15:07:34 +0530</pubDate>
<dc:creator>srsameer099</dc:creator>
<media:keywords></media:keywords>
</item>

<item>
<title>Covid Scare In India Persists As Cases Near 5000&#45;Mark, 7 Deaths Recorded In 24 Hours</title>
<link>https://news.adab.space/covid-scare-in-india-persists-as-cases-near-5000-mark-7-deaths-recorded-in-24-hours</link>
<guid>https://news.adab.space/covid-scare-in-india-persists-as-cases-near-5000-mark-7-deaths-recorded-in-24-hours</guid>
<description><![CDATA[ Cases of Covid-19 in the country are on a rise with active infections pegged at 4,302, according to the Ministry of Health and Family Welfare.&amp;nbsp;
The number of active cases in the country stood at 4,302 with 276 fresh infections reported in the last 24 hours.&amp;nbsp;
Seven people succumbed to the infection in the last 24 hours taking the nationwide toll to 44 while 3,281 patients have been discharged.&amp;nbsp;
Among seven fatalities, from was from Maharashtra and one each from Delhi, Tamil Nadu, and Gujarat. All the patients had comorbidities except the patient from Gujarat whose details were not known.
Kerala continued to report highest number of cases with 1,373 infections followed by Maharashtra (510), Gujarat (461), Delhi (457), and West Bengal (432).&amp;nbsp; ]]></description>
<enclosure url="https://feeds.abplive.com/onecms/images/uploaded-images/2025/06/04/a83f94f7cf67453973f868fe3595943c1749013950618272_original.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 30 Jun 2026 15:07:32 +0530</pubDate>
<dc:creator>srsameer099</dc:creator>
<media:keywords></media:keywords>
</item>

<item>
<title>Covid&#45;19 Fear Grows In India With More Deaths, Over 4,800 Active Cases Recorded So Far</title>
<link>https://news.adab.space/covid-19-fear-grows-in-india-with-more-deaths-over-4800-active-cases-recorded-so-far</link>
<guid>https://news.adab.space/covid-19-fear-grows-in-india-with-more-deaths-over-4800-active-cases-recorded-so-far</guid>
<description><![CDATA[ India is witnessing a renewed surge in Covid-19 infections, with the country&amp;rsquo;s active case count climbing to 4,866, as per the latest update from the Ministry of Health and Family Welfare released on Thursday morning. In the last 24 hours alone, 564 new cases and 7 fatalities have been reported.
Of the seven deceased, three were from Maharashtra, while Delhi and Karnataka reported two deaths each. Six of the seven individuals who died were elderly and had pre-existing health conditions such as diabetes, hypertension, and pneumonia. One of the deceased was a five-month-old male child with respiratory issues.
The resurgence has been attributed to new and emerging variants, including LF.7, XFG, JN.1, and the recently identified NB.1.8.1 subvariant. Since May 22, active cases have soared from just 257 to nearly 5,000, sparking concerns across states and prompting advisories from the central government.
Among the worst-hit states are Kerala, Karnataka, West Bengal, and Delhi, which recorded 114, 112, 106, and 105 new cases respectively in the last 24 hours. Kerala continues to top the chart with the highest number of active cases at 1,487, followed by Delhi (562), West Bengal (538), and Maharashtra (526).
Statewise Covid-19 Snapshot



State
Active Cases
New Cases (Last 24 Hours)
Deaths (Last 24 Hours)



Kerala


1,487


+114


0




Maharashtra


526


+16


3




Gujarat


508


+47


0




Delhi


562


+105


2




West Bengal


538


+106


0




Karnataka


436


+112


2




Tamil Nadu


213


-3


0




In light of the situation, the central government has issued advisories to all states and union territories, urging them to ensure the availability of essential medical supplies, including oxygen and life-saving medications.
Health experts are also advising the public to remain vigilant and distinguish between Covid-19 and other viral fevers, as both share similar symptoms such as fever and fatigue.
Vulnerable populations, including the elderly and those with underlying health conditions, are advised to exercise caution and seek medical attention if symptoms persist or worsen. The Indian Medical Association has recommended continued preventive measures, including mask-wearing and hand hygiene, to control the spread of the virus. ]]></description>
<enclosure url="https://feeds.abplive.com/onecms/images/uploaded-images/2025/05/31/4b7cf16f5c02c49ab9d10280d61277b717486542036061131_original.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 30 Jun 2026 15:07:29 +0530</pubDate>
<dc:creator>srsameer099</dc:creator>
<media:keywords></media:keywords>
</item>

<item>
<title>‘Stratus’ COVID Variant Spreads Rapidly Across US, Here&amp;apos;s What To Know About XFG Strain</title>
<link>https://news.adab.space/stratus-covid-variant-spreads-rapidly-across-us-heres-what-to-know-about-xfg-strain</link>
<guid>https://news.adab.space/stratus-covid-variant-spreads-rapidly-across-us-heres-what-to-know-about-xfg-strain</guid>
<description><![CDATA[ A new COVID-19 variant, known as XFG or &amp;ldquo;Stratus,&amp;rdquo; is surging across the United States, swiftly becoming the third-most common strain of the summer and raising concerns among health authorities. The fast-spreading variant, first detected in Southeast Asia in January, has also been reported in several European countries.
According to the Centers for Disease Control and Prevention (CDC), XFG accounted for virtually none of the cases in the US until April, when it registered at 2 per cent. By late May, it had climbed to 6 per cent, before doubling to 11 per cent in early June. Just weeks later, it reached 14 per cent, a sharp and steady rise.
High or very high case levels have been reported in states including Alabama, Alaska, California, Delaware, Florida, Hawaii, Kentucky, Louisiana, and Texas. Meanwhile, infections are also on the rise in other parts of the country, such as New York, Pennsylvania, North Carolina, Virginia, and Washington.
Another strain, NB.1.8.1, nicknamed &amp;ldquo;Nimbus&amp;rdquo;, is also circulating widely in the US, with reports suggesting it often causes a severe sore throat.
What We Know About XFG
The World Health Organization (WHO) describes XFG as a recombinant variant, formed from lineages LF.7 and LP.8.1.2. The earliest known sample was collected on January 27, 2025. In June, the WHO classified it as a &amp;ldquo;variant under monitoring&amp;rdquo; due to its increasing global spread.
Experts say the virus that causes COVID-19, SARS-CoV-2, continues to evolve, picking up mutations that may help it evade immune defences. Professor Subhash Verma, a microbiology and immunology expert at the University of Nevada, Reno, told USA Today that XFG&amp;rsquo;s mutations could potentially improve its ability to bypass immune responses.
However, the WHO currently assesses the public health risk posed by XFG as low, noting there is no evidence it causes more severe illness or markedly different symptoms compared to earlier Omicron strains. Current COVID-19 vaccines are still expected to protect against both symptomatic and severe disease caused by this variant.
Symptoms to Watch For
The CDC lists the following as common COVID-19 symptoms, which apply to infections caused by XFG:

Fever or chills
Cough
Shortness of breath or difficulty breathing
Sore throat
Congestion or runny nose
Loss of taste or smell
Fatigue
Muscle or body aches
Headache
Nausea or vomiting

With XFG&amp;rsquo;s presence growing, health officials continue to urge vaccination, mask use in crowded spaces, and testing for those experiencing symptoms. ]]></description>
<enclosure url="https://feeds.abplive.com/onecms/images/uploaded-images/2025/06/10/f09d5d9758dd1d6efa4c797107db143517495419951951174_original.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 30 Jun 2026 15:07:27 +0530</pubDate>
<dc:creator>srsameer099</dc:creator>
<media:keywords></media:keywords>
</item>

<item>
<title>Small Genetic Mutation Can Change How SARS&#45;CoV&#45;2 Behaves: Study</title>
<link>https://news.adab.space/small-genetic-mutation-can-change-how-sars-cov-2-behaves-study</link>
<guid>https://news.adab.space/small-genetic-mutation-can-change-how-sars-cov-2-behaves-study</guid>
<description><![CDATA[ Although viruses are known to undergo continual mutation, not all genetic alterations have a significant effect. Sometimes, a single mutation can change a virus&#039;s behavior, its ability to spread and even whether it can infect a new species. The World Health Organization (WHO) states that as viruses reproduce, they naturally pick up mutations, some of which can alter their transmissibility, severity or capacity to adapt to new hosts. Researchers who want to forecast and stop future outbreaks have made it a top priority to comprehend these genetic changes. 
Researchers from the University of California, San Francisco (UCSF) and partner institutions have discovered a single genetic alteration that seems to affect how closely related coronaviruses behave in various species. The results, which were published in the journal Cell Host &amp;amp; Microbe, provide new information about how animal viruses might develop the capacity to infect people and cause illness.
Tiny Difference With Major Consequences
RaTG13, a closely similar coronavirus found in bats and SARS-CoV-2, the virus that causes COVID-19, were compared by the researchers. Despite having a similar genetic composition, the two viruses interact with their hosts in somewhat distinct ways.
In order to find out why, researchers created the first laboratory-grown lung cell line from the larger horseshoe bat, which enables them to examine the behaviour of both viruses in human and bat lung cells under comparable circumstances. They concentrated on Orf9b, a viral protein that aids coronaviruses in avoiding the host&#039;s immune system. Surprisingly, there was just one amino acid difference across the Orf9b proteins, yet that small difference significantly altered how each virus interacted with immune defences.&amp;nbsp;
The study found that the SARS-CoV-2 form of the protein was far more successful in inhibiting the body&#039;s initial antiviral response, which allowed the virus to multiply more effectively in human cells.
ALSO READ |Oral Cancer: Tobacco And Vaping Are Putting More Young People At Risk, Know The Early Warning Signs
Why The Discovery Matters
The results, according to scientists, advance our knowledge of spillover events, the process by which viruses that are circulating in animals adapt and infect humans. Animal coronaviruses were the source of earlier outbreaks such as SARS, MERS and COVID-19, before they spread to humans.
The WHO states that it is crucial to keep an eye on viral evolution because changes that enhance a virus&#039;s capacity to infect new hosts or elude immune responses might lead to the creation of new variations. Finding the mutations with the biggest biological impact could help bolster international surveillance networks and increase readiness for pandemics in the future.
These kinds of findings, according to researchers, may help them better identify high-risk viruses before they cause epidemics. The US Centers for Disease Control and Prevention (CDC) states that genome surveillance makes it possible for scientists to track the evolution of viruses, spot significant alterations and react more quickly to new dangers to public health. While viruses are still circulating in animal populations, scientists aim to find genetic fingerprints associated with immune evasion or improved infectivity rather than waiting for a virus to proliferate widely.
ALSO READ |Is Pelvic Pressure Normal After Childbirth? Experts Explain
Not Every Mutation Leads To A New Pandemic
The finding does not imply that a single mutation can start a new pandemic, researchers warn. Before a virus can establish long-term transmission in people, it must overcome several biological obstacles. A virus&#039;s ability to transmit between individuals is influenced by a number of factors, including receptor binding, immune evasion, viral replication and environmental factors. However, scientists think the discovery offers a crucial piece of the puzzle. 
Researchers may be able to identify potentially harmful animal viruses sooner and prioritise them for surveillance by identifying genetic alterations that increase a virus&#039;s capacity to suppress immune defences. Such findings could be crucial in bolstering pandemic preparedness and directing the creation of next-generation antiviral treatments and vaccines as genome sequencing advances globally. ]]></description>
<enclosure url="https://feeds.abplive.com/onecms/images/uploaded-images/2026/06/26/8077bfb1ec07a37251f6331d39fdd2d717824788244861460_original.jpg" length="49398" type="image/jpeg"/>
<pubDate>Tue, 30 Jun 2026 15:07:26 +0530</pubDate>
<dc:creator>srsameer099</dc:creator>
<media:keywords></media:keywords>
</item>

<item>
<title>New Covid&#45;Like Virus In Thai Bats Show Ability To Infect Human Cells, Study Finds</title>
<link>https://news.adab.space/new-covid-like-virus-in-thai-bats-show-ability-to-infect-human-cells-study-finds</link>
<guid>https://news.adab.space/new-covid-like-virus-in-thai-bats-show-ability-to-infect-human-cells-study-finds</guid>
<description><![CDATA[ Scientists from Japan and Thailand have identified a new group of coronaviruses closely related to SARS-CoV-2 in horseshoe bats living in Thailand, raising fresh questions about how such viruses evolve and spread in nature.
The discovery was made by researchers from the Institute of Medical Science at The University of Tokyo and Chulalongkorn University. According to the university statement, the newly identified viruses have the ability to infect human cells, although researchers stressed that the specific viruses studied do not currently pose a threat to people.
The findings were published in the journal Cell on May 6, 2026.
ALSO READ: International Nurses Day 2026: How Florence Nightingale Changed Modern Healthcare? Know History And Significance
Why Horseshoe Bats Are Drawing Global Attention
Horseshoe bats are considered the primary natural hosts of coronaviruses related to SARS-CoV-2, the virus responsible for the COVID-19 pandemic. However, scientists say much remains unknown about the diversity of these viruses, especially across Southeast Asia, home to the world&amp;rsquo;s largest variety of horseshoe bat species.
To better understand these viruses, researchers collected samples from acuminate horseshoe bats in Thailand and studied how the newly discovered viruses compared with SARS-CoV-2.
Their investigation combined wildlife virus surveillance, laboratory experiments, and computational analysis to trace how the viruses may have moved geographically and evolved over time.
Discovery Of A New Coronavirus Group
The study identified a newly recognised category of SARS-CoV-2-related viruses, referred to as &#039;Clade B.&#039;
What makes this finding particularly significant is that Clade B viruses were found circulating alongside another previously identified group, called Clade A, inside the same artificial cave in Thailand&amp;rsquo;s Chachoengsao Province. In some cases, both virus groups were detected in the same bat.
Researchers noted a key distinction between the two clades. Unlike Clade A viruses, the newly identified Clade B viruses can use the same human receptor, ACE2, that SARS-CoV-2 relies on to infect human cells.
This suggests that different coronavirus groups can coexist within the same bat populations while potentially exchanging genetic material through recombination, a process that may alter how the viruses behave.
Laboratory Tests Reveal Lower Risk To Humans
To better understand the virus, researchers synthetically produced a representative Clade B virus known as RacCS20637 and studied its behaviour under strict Biosafety Level 3 laboratory conditions in Japan.
The experiments showed that although the virus could bind efficiently to the human ACE2 receptor, it replicated much more slowly in human cells than SARS-CoV-2.
Animal studies also offered reassuring results. Infected hamsters showed little to no signs of disease, and the virus did not spread between animals.
Researchers said these findings indicate that the virus performs far less effectively in humans compared to SARS-CoV-2.
Existing Vaccines And Antiviral Drugs Remain Effective
The study also found that RacCS20637 could be neutralised by blood serum from individuals who had received three doses of a COVID-19 vaccine.
In addition, currently available antiviral drugs used against SARS-CoV-2 were found to work effectively against the virus.
While the researchers emphasised that this specific coronavirus group does not currently threaten humans, they warned that only small genetic changes may be needed for related viruses to alter their properties. ]]></description>
<enclosure url="https://feeds.abplive.com/onecms/images/uploaded-images/2026/05/12/853aabc4749cbb2b8297ca895f504f081778567290523937_original.png" length="49398" type="image/jpeg"/>
<pubDate>Tue, 30 Jun 2026 15:07:26 +0530</pubDate>
<dc:creator>srsameer099</dc:creator>
<media:keywords></media:keywords>
</item>

</channel>
</rss>